---
title: "LIF-Engineered Mesenchymal Stromal Cells Reduce Mortality and Reprogram Cytokines in LPS Endotoxem"
id: "pubmed-42969209"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-42969209"
content_type: "clinical_feed_article"
specialty: "Critical Care"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/42969209/"
doi: "10.1111/1348-0421.70102"
published_at: "2026-11-02T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# LIF-Engineered Mesenchymal Stromal Cells Reduce Mortality and Reprogram Cytokines in LPS Endotoxem
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-42969209
- **Specialty:** [Critical Care](https://medichelpline.com/clinical-feed/critical-care.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/42969209/)
- **DOI:** [10.1111/1348-0421.70102](https://doi.org/10.1111%2F1348-0421.70102)
- **Published At:** 2026-11-02T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- The study tested mesenchymal stromal cells genetically engineered to express **leukemia inhibitory factor** (MSC-LIF) in vitro and in vivo against LPS-driven endotoxemia. - In vitro co-cultures paired LPS + IFN-γ–stimulated peritoneal macrophages with MSC-LIF or wild-type MSCs (MSC-WT); investigators reported reductions in TNF-α, IL-12, and nitric oxide when MSC-LIF were present. - MSC-LIF produced greater inhibition of IL-12 and nitrite levels than MSC-WT, while IL-6 increased in co-cultures, indicating a shifted cytokine milieu rather than simple suppression. - In a mouse model using C57BL/6 animals with lethal LPS endotoxemia, treatment arms included MSC-LIF, MSC-WT, dexamethasone, and vehicle; the highest MSC-LIF dose (1 × 10^6 cells) produced 100% survival. - Serum cytokine profiling after treatment showed marked reductions in TNF-α, IL-6, IL-1β, and IL-12 with MSC-LIF and a significant increase in **IL-10**, consistent with systemic immunoregulation. - The survival effect of MSC-LIF was dose-dependent and exceeded that of MSC-WT in the reported cohorts. - The abstract does not provide detailed protocols for MSC engineering, dosing schedule beyond the reported cell count, timing of administration relative to LPS, or sample size and statistical measures; the source did not report those methodological specifics.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/42969209/#article-details) ### NIH Websites Are Changing * [Get the Latest Updates and FAQs on the transition](https://www.nih.gov/web-modernization) * Per [Executive Order 14434](https://www.whitehouse.gov/presidential-actions/2026/09/inaugurating-the-era-of-super-intelligence/), federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition. ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42969209%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/42969209/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/42969209/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/42969209/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/42969209/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/42969209/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/42969209/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42969209%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42969209%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/42969209/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42969209/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42969209/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/42969209/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42969209/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/42969209/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/42969209/#abstract) * [ References ](https://pubmed.ncbi.nlm.nih.gov/42969209/#references) * [ Grants and funding ](https://pubmed.ncbi.nlm.nih.gov/42969209/#grants) Title & authors Abstract References Grants and funding Microbiol Immunol Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Microbiol+Immunol%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Microbiol+Immunol%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42969209/) . 2026 Nov 2. doi: 10.1111/1348-0421.70102. Online ahead of print. # In Vitro and In Vivo Immunomodulatory and Protective Effects of Leukemia Inhibitory Factor-Engineered Mesenchymal Stromal Cells in Experimental Endotoxemia [Alana Costa de Oliveira](https://pubmed.ncbi.nlm.nih.gov/?term=Oliveira+AC&cauthor_id=42969209)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42969209/#full-view-affiliation-1 "Instituto Gonçalo Moniz, Fundação Oswaldo Cruz \(FIOCRUZ\), Salvador, Bahia, Brazil.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42969209/#full-view-affiliation-2 "Instituto SENAI de Inovação em Sistemas Avançados de Saúde \(ISI SAS\), Universidade SENAI CIMATEC, Salvador, Bahia, Brazil."), [Diego de Carvalho Carneiro](https://pubmed.ncbi.nlm.nih.gov/?term=Carneiro+DC&cauthor_id=42969209)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42969209/#full-view-affiliation-1 "Instituto Gonçalo Moniz, Fundação Oswaldo Cruz \(FIOCRUZ\), Salvador, Bahia, Brazil.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42969209/#full-view-affiliation-2 "Instituto SENAI de Inovação em Sistemas Avançados de Saúde \(ISI SAS\), Universidade SENAI CIMATEC, Salvador, Bahia, Brazil."), [Luiza Carolina França Opretzka](https://pubmed.ncbi.nlm.nih.gov/?term=Opretzka+LCF&cauthor_id=42969209)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42969209/#full-view-affiliation-2 "Instituto SENAI de Inovação em Sistemas Avançados de Saúde \(ISI SAS\), Universidade SENAI CIMATEC, Salvador, Bahia, Brazil."), [Breno Cardim Barreto](https://pubmed.ncbi.nlm.nih.gov/?term=Barreto+BC&cauthor_id=42969209)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42969209/#full-view-affiliation-1 "Instituto Gonçalo Moniz, Fundação Oswaldo Cruz \(FIOCRUZ\), Salvador, Bahia, Brazil."), [Dahara Keyse Carvalho Silva](https://pubmed.ncbi.nlm.nih.gov/?term=Silva+DKC&cauthor_id=42969209)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42969209/#full-view-affiliation-1 "Instituto Gonçalo Moniz, Fundação Oswaldo Cruz \(FIOCRUZ\), Salvador, Bahia, Brazil."), [Girlaine Café Santos](https://pubmed.ncbi.nlm.nih.gov/?term=Santos+GC&cauthor_id=42969209)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42969209/#full-view-affiliation-1 "Instituto Gonçalo Moniz, Fundação Oswaldo Cruz \(FIOCRUZ\), Salvador, Bahia, Brazil.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42969209/#full-view-affiliation-2 "Instituto SENAI de Inovação em Sistemas Avançados de Saúde \(ISI SAS\), Universidade SENAI CIMATEC, Salvador, Bahia, Brazil."), [Cássio Santana Meira](https://pubmed.ncbi.nlm.nih.gov/?term=Meira+CS&cauthor_id=42969209)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42969209/#full-view-affiliation-1 "Instituto Gonçalo Moniz, Fundação Oswaldo Cruz \(FIOCRUZ\), Salvador, Bahia, Brazil.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42969209/#full-view-affiliation-2 "Instituto SENAI de Inovação em Sistemas Avançados de Saúde \(ISI SAS\), Universidade SENAI CIMATEC, Salvador, Bahia, Brazil."), [Milena Botelho Pereira Soares](https://pubmed.ncbi.nlm.nih.gov/?term=Soares+MBP&cauthor_id=42969209)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42969209/#full-view-affiliation-1 "Instituto Gonçalo Moniz, Fundação Oswaldo Cruz \(FIOCRUZ\), Salvador, Bahia, Brazil.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42969209/#full-view-affiliation-2 "Instituto SENAI de Inovação em Sistemas Avançados de Saúde \(ISI SAS\), Universidade SENAI CIMATEC, Salvador, Bahia, Brazil.") Affiliations Expand ### Affiliations * 1 Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Bahia, Brazil. * 2 Instituto SENAI de Inovação em Sistemas Avançados de Saúde (ISI SAS), Universidade SENAI CIMATEC, Salvador, Bahia, Brazil. * PMID: **42969209** * DOI: [ 10.1111/1348-0421.70102 ](https://doi.org/10.1111/1348-0421.70102) Item in Clipboard # In Vitro and In Vivo Immunomodulatory and Protective Effects of Leukemia Inhibitory Factor-Engineered Mesenchymal Stromal Cells in Experimental Endotoxemia Alana Costa de Oliveira et al. Microbiol Immunol. 2026. Show details Display options Display options Format Abstract PubMed PMID Microbiol Immunol Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Microbiol+Immunol%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Microbiol+Immunol%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42969209/) . 2026 Nov 2. doi: 10.1111/1348-0421.70102. Online ahead of print. ### Authors [Alana Costa de Oliveira](https://pubmed.ncbi.nlm.nih.gov/?term=Oliveira+AC&cauthor_id=42969209)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42969209/#short-view-affiliation-1 "Instituto Gonçalo Moniz, Fundação Oswaldo Cruz \(FIOCRUZ\), Salvador, Bahia, Brazil.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42969209/#short-view-affiliation-2 "Instituto SENAI de Inovação em Sistemas Avançados de Saúde \(ISI SAS\), Universidade SENAI CIMATEC, Salvador, Bahia, Brazil."), [Diego de Carvalho Carneiro](https://pubmed.ncbi.nlm.nih.gov/?term=Carneiro+DC&cauthor_id=42969209)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42969209/#short-view-affiliation-1 "Instituto Gonçalo Moniz, Fundação Oswaldo Cruz \(FIOCRUZ\), Salvador, Bahia, Brazil.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42969209/#short-view-affiliation-2 "Instituto SENAI de Inovação em Sistemas Avançados de Saúde \(ISI SAS\), Universidade SENAI CIMATEC, Salvador, Bahia, Brazil."), [Luiza Carolina França Opretzka](https://pubmed.ncbi.nlm.nih.gov/?term=Opretzka+LCF&cauthor_id=42969209)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42969209/#short-view-affiliation-2 "Instituto SENAI de Inovação em Sistemas Avançados de Saúde \(ISI SAS\), Universidade SENAI CIMATEC, Salvador, Bahia, Brazil."), [Breno Cardim Barreto](https://pubmed.ncbi.nlm.nih.gov/?term=Barreto+BC&cauthor_id=42969209)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42969209/#short-view-affiliation-1 "Instituto Gonçalo Moniz, Fundação Oswaldo Cruz \(FIOCRUZ\), Salvador, Bahia, Brazil."), [Dahara Keyse Carvalho Silva](https://pubmed.ncbi.nlm.nih.gov/?term=Silva+DKC&cauthor_id=42969209)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42969209/#short-view-affiliation-1 "Instituto Gonçalo Moniz, Fundação Oswaldo Cruz \(FIOCRUZ\), Salvador, Bahia, Brazil."), [Girlaine Café Santos](https://pubmed.ncbi.nlm.nih.gov/?term=Santos+GC&cauthor_id=42969209)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42969209/#short-view-affiliation-1 "Instituto Gonçalo Moniz, Fundação Oswaldo Cruz \(FIOCRUZ\), Salvador, Bahia, Brazil.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42969209/#short-view-affiliation-2 "Instituto SENAI de Inovação em Sistemas Avançados de Saúde \(ISI SAS\), Universidade SENAI CIMATEC, Salvador, Bahia, Brazil."), [Cássio Santana Meira](https://pubmed.ncbi.nlm.nih.gov/?term=Meira+CS&cauthor_id=42969209)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42969209/#short-view-affiliation-1 "Instituto Gonçalo Moniz, Fundação Oswaldo Cruz \(FIOCRUZ\), Salvador, Bahia, Brazil.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42969209/#short-view-affiliation-2 "Instituto SENAI de Inovação em Sistemas Avançados de Saúde \(ISI SAS\), Universidade SENAI CIMATEC, Salvador, Bahia, Brazil."), [Milena Botelho Pereira Soares](https://pubmed.ncbi.nlm.nih.gov/?term=Soares+MBP&cauthor_id=42969209)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42969209/#short-view-affiliation-1 "Instituto Gonçalo Moniz, Fundação Oswaldo Cruz \(FIOCRUZ\), Salvador, Bahia, Brazil.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42969209/#short-view-affiliation-2 "Instituto SENAI de Inovação em Sistemas Avançados de Saúde \(ISI SAS\), Universidade SENAI CIMATEC, Salvador, Bahia, Brazil.") ### Affiliations * 1 Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Bahia, Brazil. * 2 Instituto SENAI de Inovação em Sistemas Avançados de Saúde (ISI SAS), Universidade SENAI CIMATEC, Salvador, Bahia, Brazil. * PMID: **42969209** * DOI: [ 10.1111/1348-0421.70102 ](https://doi.org/10.1111/1348-0421.70102) Item in Clipboard Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract Sepsis is a life-threatening condition characterized by dysregulated systemic inflammation and high mortality rates. Mesenchymal stem/stromal cells (MSCs) have emerged as promising immunomodulatory agents; however, genetic engineering strategies can enhance their therapeutic efficacy. This study evaluated the immunomodulatory and protective effects of MSCs genetically engineered to express leukemia inhibitory factor (MSC-LIF) in vitro and in a mouse model of lipopolysaccharide (LPS)-induced endotoxemia. In vitro, peritoneal macrophages stimulated with LPS + IFN-γ were co-cultured with MSC-LIF or wild-type MSCs (MSC-WT). MSC-LIF significantly reduced the production of TNF-α, IL-12, and nitric oxide compared with stimulated controls and demonstrated enhanced inhibition of IL-12 and nitrite levels relative to MSC-WT. Although IL-6 levels increased in co-cultures, MSC-LIF promoted a regulatory cytokine profile characterized by modulation of pro-inflammatory mediators. In vivo, C57BL/6 mice subjected to lethal endotoxemia with LPS were treated with MSC-LIF, MSC-WT, dexamethasone, or vehicle. MSC-LIF significantly improved survival in a dose-dependent manner, achieving 100% survival at the highest dose (1 × 106 cells), outperforming MSC-WT. Serum cytokine analysis revealed that MSC-LIF markedly reduced TNF-α, IL-6, IL-1β, and IL-12 levels while significantly increasing IL-10 production, indicating enhanced systemic immunoregulation. Collectively, these findings demonstrate that LIF expression potentiates the immunomodulatory and protective effects of MSCs in experimental endotoxemia. MSC-LIF therapy promotes a balanced inflammatory response and significantly improves survival, supporting its potential as a novel therapeutic strategy for severe systemic inflammatory conditions such as sepsis. **Keywords:** endotoxemia; immunomodulation; inflammation; leukemia inhibitory factor; mesenchymal stromal cells; sepsis. © 2026 The Author(s). Microbiology and Immunology published by The Societies and John Wiley & Sons Australia, Ltd. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## References 1. 1. R. Medzhitov, “Origin and Physiological Roles of Inflammation,” Nature 454, no. 7203 (2008): 428–435, . 2. 1. J. R. Dunkelberger and W. C. Song, “Complement and Its Role in Innate and Adaptive Immune Responses,” Cell Research 20, no. 1 (2010): 34–50, . 3. 1. H. Chen, X. Ling, B. Zhao, et al., “Mesenchymal Stem Cells From Different Sources for Sepsis Treatment: Prospects and Limitations,” Brazilian Journal of Medical and Biological Research 57 (2024): e13457, . 4. 1. M. Singer, C. S. Deutschman, C. W. Seymour, et al., “The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis‐3),” Journal of the American Medical Association 315, no. 8 (2016): 801–810, . 5. 1. B. Gyawali, K. Ramakrishna, and A. S. Dhamoon, “Sepsis: The Evolution in Definition, Pathophysiology, and Management,” SAGE Open Medicine 7 (2019): 2050312119835043, . Show all 38 references ## Grants and funding * [ Coordenação de Aperfeiçoamento de Pessoal de Nível Superior ](https://pubmed.ncbi.nlm.nih.gov/?term=Coordena%C3%A7%C3%A3o+de+Aperfei%C3%A7oamento+de+Pessoal+de+N%C3%ADvel+Superior%5BGrants+and+Funding%5D&sort=date&sort_order=desc "All articles for grant Coordenação de Aperfeiçoamento de Pessoal de Nível Superior") * [ Conselho Nacional de Desenvolvimento Científico e Tecnológico ](https://pubmed.ncbi.nlm.nih.gov/?term=Conselho+Nacional+de+Desenvolvimento+Cient%C3%ADfico+e+Tecnol%C3%B3gico%5BGrants+and+Funding%5D&sort=date&sort_order=desc "All articles for grant Conselho Nacional de Desenvolvimento Científico e Tecnológico") * [ Fundação Oswaldo Cruz ](https://pubmed.ncbi.nlm.nih.gov/?term=Funda%C3%A7%C3%A3o+Oswaldo+Cruz%5BGrants+and+Funding%5D&sort=date&sort_order=desc "All articles for grant Fundação Oswaldo Cruz") [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM **Send To** * [Clipboard](https://pubmed.ncbi.nlm.nih.gov/42969209/) * [Email](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42969209%2F%23open-email-panel) * [Save](https://pubmed.ncbi.nlm.nih.gov/42969209/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42969209%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42969209%2F%23open-collections-panel) * [Citation Manager](https://pubmed.ncbi.nlm.nih.gov/42969209/) [x] NCBI Literature Resources [MeSH](https://www.ncbi.nlm.nih.gov/mesh/) [PMC](https://www.ncbi.nlm.nih.gov/pmc/) [Bookshelf](https://www.ncbi.nlm.nih.gov/books) [Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited. Follow NCBI [ Twitter ](https://twitter.com/ncbi) [ Facebook ](https://www.facebook.com/ncbi.nlm) [ LinkedIn ](https://www.linkedin.com/company/ncbinlm) [ GitHub ](https://github.com/ncbi) [ ](https://ncbiinsights.ncbi.nlm.nih.gov/) [Connect with NLM](https://www.nlm.nih.gov/socialmedia/index.html) * [ Twitter ](https://twitter.com/NLM_NIH) * [ SM-Facebook ](https://www.facebook.com/nationallibraryofmedicine) * [ SM-Youtube ](https://www.youtube.com/user/NLMNIH) National Library of Medicine [8600 Rockville Pike Bethesda, MD 20894](https://www.google.com/maps/place/8600+Rockville+
## Related Clinical Research

- [Aggressive NK‑cell Leukemia with HLH and Organ Failure Bridged to Allogeneic HSCT — Case Report](https://medichelpline.com/clinical-feed/frontiers-in-immunology-15-case-report-fulminant-aggressive-nk-cell-leukemia-with-hemophagocytic.md)
- [Lenabasum reduces CLP-induced sepsis-associated acute lung injury by modulating redox and inflamma](https://medichelpline.com/clinical-feed/pubmed-43040058.md) (DOI: 10.1007/s00210-026-06101-2)
- [Corticosteroid Therapy in Pneumonia and Critical Illness: Agent Selection, Dosing, Monitoring, Int](https://medichelpline.com/clinical-feed/pubmed-42638128.md) (DOI: 10.1186/s41479-026-00209-y)
- [Multiomic predictors of minimal residual disease after Isa-KRd induction in newly diagnosed multip](https://medichelpline.com/clinical-feed/nature-1-molecular-predictors-of-minimal-residual-disease-in-newly-diagnosed-multiple.md)
- [Piecing Together the Adrenal Puzzle: CAI Score and Postoperative Testing](https://medichelpline.com/clinical-feed/endocrine-news-1-piecing-together-the-adrenal-puzzle.md)

## Navigation
- [← Back to Critical Care Feed](https://medichelpline.com/clinical-feed/critical-care.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.